dexcom g5 (Dexcom Inc)
86
Structured Review
Dexcom Inc
dexcom g5
Dexcom G5, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dexcom+g5/dexcom+g5/pmc13268403-120-21-21
Average 86 stars, based on 1 article reviews
Dexcom G5, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dexcom+g5/dexcom+g5/pmc13268403-120-21-21
Average 86 stars, based on 1 article reviews
dexcom g5 - by Bioz Stars,
2026-09
86/100 stars
Images
Related Articles
other:Article Title: A Review of the Fear of Hypoglycemia Literature in Children and Adolescents with Type 1 Diabetes and their Caregivers Article Snippet: Burckhardt and colleagues [ ] conducted a 3-month long crossover study in which children ages 2–12 years were randomized to use either the Article Title: Continuous Glucose Monitoring in Diabetes Care in Saudi Arabia: Addressing Performance Standards and Regulatory Gaps-Literature Review and Consensus Report. Article Snippet: Both systems showed similar time-in-range (~68%) and variability, but the time spent below, and above range differed, with FreeStyle Libre reporting twice the low-glucose time compared to Article Title: Continuous Glucose Monitoring in Diabetes Care in Saudi Arabia: Addressing Performance Standards and Regulatory Gaps—Literature Review and Consensus Report Article Snippet: Both systems showed similar time-in-range (~68%) and variability, but the time spent below, and above range differed, with FreeStyle Libre reporting twice the low-glucose time compared to Article Title: A Review of the Fear of Hypoglycemia Literature in Children and Adolescents with Type 1 Diabetes and their Caregivers. Article Snippet: Burckhardt and colleagues [52] conducted a 3-month long crossover study in which children ages 2–12 years were randomized to use either the Clinical Proteomics:Article Title: Sensor-based digital health technologies to capture endpoints in recent clinical trials: a scoping review. Article Snippet: .. The majority of publications (n = 38; 79%) described the use of sensors to measure physiological data, and most (n = 36) used continuous glucose monitoring (CGM) in clinical trials conducted primarily in patients with type 1 diabetes (Figure 2 and Table 1).38-75 Of the studies using CGM, 44% (n = 16) were conducted among adults only,43-46,49,57,58,62,64-67,69,71,74,75 33% (n = 12) were conducted among children,40,41,52,55,56,60,61,63,68,70,72,73 and 22% (n = 8) included both adults and children.42,47,48,50,51,54,59,73 Commonly used CGM systems included the |